Steven Seedhouse

Stock Analyst at Raymond James

(0)
# 4714
Out of 5,370 analysts
264
Total ratings
33.33%
Success rate
-16.07%
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
MIRM Mirum Pharmaceutical...
Maintains: Strong Buy
73 77
50.3 53.08% 19 May 13, 2025
WVE WAVE Life Sciences
Initiates Coverage On: Overweight
10
6.84 46.2% 3 Apr 29, 2025
KRRO Korro Bio
Initiates Coverage On: Overweight
74
13.34 454.72% 2 Apr 29, 2025
PHVS Pharvaris
Initiates Coverage On: Overweight
28
16.62 68.47% 1 Apr 29, 2025
ATXS Astria Therapeutics
Initiates Coverage On: Overweight
47
5.93 692.58% 1 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
10
0.78 1182.05% 14 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
20
10.27 94.74% 1 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
104
26.95 285.9% 19 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
90 22
1.69 1201.78% 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
51 56
18.22 207.35% 3 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
53 49
10.03 388.53% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
6 14
1.9 636.84% 6 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
93
110.72 -16% 9 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
57 68
21.85 211.21% 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 11 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33 33
n/a n/a 12 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
67 106
18.32 478.6% 15 Jan 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 15
3.67 308.72% 2 Jan 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 56
13.81 305.5% 4 Jan 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 18
n/a n/a 8 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 57
8.96 536.16% 10 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
20 22
1.2 1733.33% 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
17
2.15 690.7% 6 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 17 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 35
2.88 1115.28% 4 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
38
46.85 -18.89% 2 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 6
n/a n/a 7 Apr 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 10 Feb 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 71
29.84 137.94% 4 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 5
1.28 290.62% 5 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 38
23.89 59.06% 2 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Aug 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 7 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 14 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 May 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
285 270
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 10
n/a n/a 3 Mar 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 10 Jan 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Apr 23, 2020